China Bio Energy Reports Fourth Quarter and Record 2008 Financial Results
Posted on: Monday, 23 March 2009, 07:00 CDT
For more information about the non-GAAP financial measures contained in this press release, please see ''About Non-GAAP Financial Measures" below.
Fourth Quarter 2008 Financial Results
Sales - Sales for the fourth quarter of 2008 were
''We are very pleased with our progress during the fourth quarter,''
stated Mr. Gao Xincheng, Chief Executive Officer of China Bio Energy Holdings
Group. ''The Company's bio-diesel sales increased 255% for the fourth quarter
of 2008, compared to the fourth quarter of 2007. Despite declining oil prices
in
Cost of Sales - Cost of sales for the fourth quarter of 2008 was
Gross Profit and Gross Margin - Gross profit was
Operating Expenses - Selling, general and administrative expenses for the
fourth quarter of 2008 were approximately
Net Income - For the quarter ended
Fiscal Year 2008 Financial Results
Sales - Sales for 2008 were
Cost of Sales - Cost of sales for 2008 was
Gross Profit and Gross Margin - Gross profit was
Operating Expenses - Selling, general and administrative expenses for 2008
were approximately
Net Income - GAAP Net income for 2008 was
Liquidity and Capital Resources
Cash and cash equivalents were
Financial Outlook for 2009
Management expects to report fiscal year 2009 revenues of at least
Business Outlook for 2009
China Bio Energy's management plans to focus on growing its bio-diesel
production, its distribution business, and expanding the footprint of its
retail service stations. On the distribution and retail side, the Company
benefits from its advantageous location, well-established supplier
relationships as well as an extensive distribution network that has valuable
railway access to reach remote parts of
The Company also plans to expand its current bio-diesel production
capacity of 100,000 tons to 150,000 tons, either through strategic
acquisitions or through a new build-out in 2009. The Company anticipates
Management believes the increase in sales volume from these initiatives will not only offset the impact of current decrease in fuel prices but also favorably impact overall profits.
"Our proprietary bio-diesel production capabilities allow us to utilize
multiple types of feedstock, which provide better input cost controls while
ensuring optimal capacity utilization. We are the only integrated bio-diesel
producer in
Conference Call Information
Management will host an earnings conference call on
This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at http://www.viavid.net or at the following link: http://viavid.net/dce.aspx?sid=00005FF9 . To access the web cast, you will need to have the Windows Media Player on your desktop. For the free download of the Media Player please visit: http://www.microsoft.com/windows/windowsmedia/en/download/default.asp.
About China Bio Energy Holdings Group
CBEH is a distributor of refined oil products including gasoline, diesel,
and heavy oil, and a manufacturer and distributor of bio-diesel fuel. CBEH's
bio-diesel fuel is made at its 100,000-ton capacity facility in
Safe Harbor Statement
This press release contains certain statements that may include "forward-looking statements". All statements other than statements of historical fact included herein are "forward-looking statements". These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
About Non-GAAP Financial Measures
To supplement our consolidated financial statements, which statements are prepared and presented in accordance with GAAP, we use the following non-GAAP financial measures: non-GAAP net income, and non-GAAP EPS. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.
We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non- GAAP financial measures provide meaningful supplemental information regarding our performance and liquidity by excluding certain expenses and expenditures that may not be indicative of our ''recurring core business operating results,'' meaning our operating performance excluding not only non-cash charges, such as stock-based compensation, but also discrete cash charges that are infrequent in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal comparisons to our historical performance and liquidity as well as comparisons to our competitors' operating results. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and (2) they are used by our institutional investors and the analyst community to help them analyze the health of our business.
For more information, please contact: China Bio Energy Holdings Group Alex Gong, VP of Capital Market Tel: +86-136-0127-9912 Email: alexgong08@gmail.com Web: http://www.cbeh.net.cn/ OR HC International, Inc. Ted Haberfield, Executive VP Tel: +1-760-755-2716 Email: thaberfield@hcinternational.net Web: http://www.hcinternational.net CHINA BIO ENERGY HOLDING GROUP CO., LTD. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS For The Year Ended December 31, December 31, 2008 2007 ASSETS CURRENT ASSETS Cash and cash equivalents $23,119,028 $1,382,371 Restricted cash 919,351 200,000 Accounts receivable 8,164,320 288,589 Other receivables and deposits 3,986,984 4,403,762 Prepaid expenses 1,884,102 41,412 Advance to suppliers 17,945,487 16,546,506 Inventories, net 22,268,903 12,082,962 Due from related party -- 593,696 Total current assets 78,288,175 35,539,298 Prepaid rents 6,408,568 -- Property and equipment, net 9,997,674 8,166,250 Total noncurrent assets 16,406,242 8,166,250 TOTAL ASSETS $94,694,417 $43,705,548 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable $ -- $179,617 Advance from customers 4,580,462 499,908 Taxes payable 735,461 125,015 Other payables 3,232,088 3,233,552 Loans payable 2,247,197 1,438,164 Total current liabilities 10,795,208 5,476,256 Loans payable - Non-current -- 33,655 TOTAL LIABILITIES 10,795,208 5,509,911 STOCKHOLDERS' EQUITY Preferred stock, $.001 par value; authorized shares 10,000,000; issued and outstanding 3,465,753 and 1,000,000 shares at December 31, 2008 and 2007, respectively 3,465 1,000 Common stock, $.0001 par value; authorized shares 79,000,000; issued and outstanding 27,169,091 and 25,454,545 shares at December 31, 2008 and 2007, respectively 2,716 2,545 Additional paid in capital 44,434,250 19,611,938 Statutory reserve 4,920,114 2,051,030 Accumulated other comprehensive income 5,337,003 2,319,732 Retained earnings 29,201,661 14,209,392 Total stockholders' equity 83,899,209 38,195,637 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $94,694,417 $43,705,548 CHINA BIO ENERGY HOLDING GROUP CO., LTD. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME For The Year Ended December 31, 2008 December 31, 2007 Sales $216,506,969 $87,104,187 Cost of goods sold 185,858,502 77,006,690 Gross profit 30,648,467 10,097,497 Selling, general and administrative expenses 1,997,818 1,686,760 Income from operations 28,650,649 8,410,737 Non-operating income (expenses) Interest expenses (125,201) (142,442) Subsidy income 100,792 328,697 Other expense (63,519) (17,427) Stock based compensation - make good provision (9,838,354) -- Total non-operating expenses (9,926,282) 168,828 Net income 18,724,367 8,579,565 Other comprehensive item Foreign currency translation gain 3,017,271 1,694,926 Comprehensive Income $21,741,638 $10,274,491 Net Income 18,724,367 8,579,565 Deemed dividend to preferred stockholders 863,014 3,398,534 Net income available to common stockholders 17,861,353 5,181,031 Basic and diluted weighted average shares outstanding Basic 25,889,748 24,238,107 Diluted 32,877,570 25,145,122 Basic and diluted net earnings per share available to common stockholders Basic $0.69 $0.21 Diluted $0.54 $0.21 CHINA BIO ENERGY HOLDING GROUP CO., LTD. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOW For The Year Ended December 31, December 31, 2008 2007 CASH FLOWS FROM OPERATING ACTIVITIES: Net income $18,724,367 $8,579,565 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation 1,040,924 228,833 Bad debt expenses -- -- Stock based compensation - make good provision 9,838,354 -- Stock based compensation - stocks to employees 9,945 -- (Increase) decrease in current assets: Accounts receivable (7,731,421) 5,644,946 Other receivables, deposits and prepaid expenses (8,466,631) (4,099,356) Advance to suppliers (280,790) (11,484,067) Inventories (9,223,710) (4,098,099) Due from related party 623,581 (245,852) Increase (decrease) in current liabilities: Accounts payable (187,219) (1,889,778) Advance from customers 3,982,577 87,896 Taxes payable 592,462 (643,780) Other payables and accrued expenses (217,054) 2,811,389 Net cash provided by (used in) operating activities 8,705,385 (5,108,303) CASH FLOWS FROM INVESTING ACTIVITIES: Sale of investment -- -- Acquisition of property and equipment (1,251,231) (6,809,173) Construction in progress -- -- Net cash used in investing activities (1,251,231) (6,809,173) CASH FLOWS FROM FINANCING ACTIVITIES: Restricted cash (718,768) 457,811 Notes payable - trade -- -- Notes payable - related party -- -- Proceeds from short-term loans 719,942 269,531 Repayment of short term loan -- (1,577,744) Proceeds from long-term payables -- -- Repayment of auto loans long term notes payable (54,375) (4,235) Proceeds from issuance of preferred stock 9,000,000 9,774,993 Proceeds from warrants exercised 5,113,635 -- Capital contribution -- 3,905,724 Advance to shareholder -- -- Repayment from shareholder -- 22,617 Net cash provided by financing activities 14,060,434 12,848,697 EFFECT OF EXCHANGE RATE CHANGE ON CASH AND CASH EQUIVALENTS 222,069 (180,293) NET INCREASE IN CASH AND CASH EQUIVALENTS 21,736,657 750,928 CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 1,382,371 631,443 CASH AND CASH EQUIVALENTS, END OF YEAR $23,119,028 $1,382,371 Supplemental Cash flow data: Income tax paid $ -- $ -- Interest paid $125,201 $137,463 CHINA BIO ENERGY HOLDING GROUP CO., LTD. AND SUBSIDIARIES CONSOLIDATED PROFIT AND LOSS STATEMENTS For The Three Months Ended December 31, December 31, 2008 2007 Sales 59,057,147 22,269,492 Cost of goods sold 51,549,964 19,553,247 Gross Profit 7,507,183 2,716,245 12.7% 12.2% Operating expenses Selling expenses -- -- General and administrative expenses 1,035,373 885,273 Total operating expenses 1,035,373 885,273 Income from operations 6,471,810 1,830,972 11.0% 8.2% Non-operating income (expense) Interest expenses (31,714) (43,594) Subsidy income 116,157 328,697 Other income (expenses) (60,901) (17,427) Stock-based compensation - make good provision (9,838,354) -- Total Non-operating income (expense) (9,814,812) 267,676 Net income (3,343,002) 2,098,648 -5.7% 9.4% Other comprehensive item Foreign currency translation gain (loss) (172,446) 1,189,031 Comprehensive income (3,515,448) 3,287,679 -6.0% 14.8% Net income (3,343,002) 2,098,648 Deemed dividend to preferred stockholders 863,014 3,398,534 Net income available to common stockholders (4,206,016) (1,299,886) Basic and diluted weighted average shares outstanding Basic 25,819,011 24,238,107 diluted 32,817,152 25,145,122 Basic and diluted net earnings per share available to common stockholders Basic -0.16 -0.05 Diluted -0.13 -0.05 Net Income (GAAP based) vs. Net Income (Non-GAAP Based) For The Year Ended December 31, 2008 Net Income (GAAP) 18,724,367 Stock-based Compensation -Make Good Provision 9,838,354 Net Income (Non-GAAP) 28,562,721SOURCE China Bio Energy Holdings Group
Source: PR Newswire
Related Articles
- RPM Reports Record First-Quarter Net Income, Earnings Per Share and Cash Flow
- General Mills Fiscal 2008 Net Sales Up
- Net Farm Income Rebounded in 2007 After Two Straight Drops: StatsCan
- Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
- Gardasil, Other New Products Spur Strong Vaccine Sales in 2007
- Royal Utilities Income Fund Reports 2007 Earnings
- TXCO Resources Reports 36% Increase in Sales for 2007
- Australia Opens Doors to World's Largest Exotic ''Nature Bank'' -- a 400,000 Compound Library for Drug Development -- at BIO 2007
- Z Trim Holdings, Inc. Reports Increased Z Trim Sales for 2007 and Achievement of Significant Progress In Business Plan Implementation
- Hecla Reports Dramatic Increase in Second Quarter 2006 Income, Sales, Gross Profit and Cash Flow; For the Period Ended June 30, 2006
User Comments (0)

RSS Feeds